Toray Industries is a major manufacturer of synthetic fibres and textiles, with 200 subsidiaries and affiliated companies in 18 countries and regions around the world. Headquartered in Japan, it has around 38,600 employees.
History
The company was founded in 1926.
The group's businesses include:
Fibres and Textiles
Toray handles all three major synthetic fibres - nylon, Tetoron (polyester), and Toraylon (acrylic). The company markets filament yarns and staple fibres, as well as textiles and processed products. It claims to hold the largest market share of nylon in Japan.
Plastics and Chemicals
Toray processes a diverse range of high performance resins, including Amilan (nylon), Toyolac (ABS), Toraycon (PBT), and Torelina (PPS), for use in electronic components, automotive parts, and a number of other industrial products.
The company has established production and processing bases in the US, southeast Asia and China, as well as Japan, and is now pursuing further global development and business expansion by taking its focus beyond raw materials to include processed goods.
In the chemical sector, Toray works with such synthetic fibres and plastic raw materials as caprolactam and terephthalic acid, as well as with fine chemicals and speciality chemical products. At the same time, the company is moving into a number of business sectors by capitalising on its expertise in synthetic chemistry and biotechnology with such products as Intercat, the world's first genetically engineered feline interferon, and Coatax, an acrylic resin used in paint products.
IT-related products
Toray has developed a number of films and resin for IT-related industries.
Carbon Fibre Composite Materials
Carbon fibre, advanced composite materials and fabricated products.
Environment and Engineering
This business comprises of engineering; condominiums and homes; industrial machinery; environmental equipment; water treatment membranes and related equipment; materials for housing, building and civil engineering applications.
Life Sciences and Other Products
In the pharmaceuticals sector, Toray has offered such products as Japan's first natural interferon-b preparation, Feron, and the world's first orally active prostacyclin preparation, Dorner.
The company's medical devices include Filtryzer and Toraysulfone artificial kidneys and the extra-corporeal blood purification column Toraymyxin. Toray will continue to develop and expand its business in these fields to meet the needs of the life science sector, a market with strong growth potential.
Toray Industries
Strategy & Financial Highlights
Toray will focus on core technologies; synthetic organic chemistry, polymer chemistry, nanotechnology, and biotechnology to globally expand a variety of businesses, namely, “foundation businesses” (Fibres and Textiles and Plastics and Chemicals), “strategically expanding businesses” (IT-related Products and Carbon Fibre Composite Materials) and “strategically developing businesses” (including pharmaceuticals, medical products and water treatment). (Edited from annual report and company website). ICIS also provides you with key financial data listed in table form.
More about Toray Industries Strategy & Financial Highlights
News:
Get news on Toray Industries plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database